INTELLECTUAL PROPERTY PROTECTION, BIOTECHNOLOGY AND DEVELOPING COUNTRIES: WILL THE TRIPS BE EFFECTIVE?
William A. Kerr, Jill E. Hobbs, Revadee Yampoin
Abstract
William A. Kerr, Jill E. Hobbs, Revadee Yampoin
Abstract
The international protection of intellectual property has been a contentious issue between developed and developing countries. Protection of intellectual property rights in agricultural biotechnology is the latest manifestation of the dispute with both developed and developing countries accusing each other of bio-piracy. The Agreement on Trade Related Aspects of Intellectual Property (TRIPs) was only grudgingly agreed to by developing countries at the Uruguay Round of WTO negotiations. The WTO allows trade retaliation to be used for violations of TRIPs commitments. The paper investigates the likely efficacy of trade measures in encouraging countries to live up to their TRIPs commitments. The results suggest that developed countries will not receive the protection they desire and, hence, there may be a mutual interest in re-opening negotiations related to patenting genetic material.
OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The international protection of intellectual property has been a contentious issue between developed and developing countries. Protection of intellectual property rights in agricultural biotechnology is the latest manifestation of the dispute with both developed and developing countries accusing each other of bio-piracy. The Agreement on Trade Related Aspects of Intellectual Property (TRIPs) was only grudgingly agreed to by developing countries at the Uruguay Round of WTO negotiations. The WTO allows trade retaliation to be used for violations of TRIPs commitments. The paper investigates the likely efficacy of trade measures in encouraging countries to live up to their TRIPs commitments. The results suggest that developed countries will not receive the protection they desire and, hence, there may be a mutual interest in re-opening negotiations related to patenting genetic material.
Key concepts: Intellectual property, TRIPS architecture, International trade, Developing country, Negotiation, TRIPS Agreement, Business, World trade